GNR-038
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GNR-038, covering 2022-02-04 to 2022-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema [Phase 2, Phase 3]